Rajalakshmi Rajendran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rajalakshmi Rajendran has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Girish Thunga
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India
2 shared publications - Sreeja Chandrasekharan Nair
Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus
2 shared publications Aiswarya Radhakrishnan
Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi- 682041, Kerala, India
1 shared publication- Arundhasree Kunnil
Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi- 682041, Kerala, India
1 shared publication Jayaraj Mymbilly Balakrishnan
Department of Emergency Medicine, Kasturba Medical College and Hospital, Manipal Academy of Higher Education, Manipal, India
1 shared publication- Jayaraj Mymbilly Balakrishnan
Department of Emergency Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India
1 shared publication
Latest Publications
- Open Access
- 5 February 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (5) , 1024-1034
Perspectives of health care professionals and policymakers on antimicrobial stewardship and implementation challenges in low- and middle-income country hospital settings: a qualitative systematic review protocol
Objective: The objective of this review is to synthesize qualitative evidence on the perceptions of health care professionals and policymakers regarding barriers and facilitators to implementing antimicrobial stewardship (AMS) programs in hospital settings, particularly in low- and middle-income countries. Introduction: AMS programs are widely recognized as critical interventions to combat antimicrobial resistance and optimize the use of antibiotics. While quantitative studies have demonstrated the effectiveness of AMS programs in reducing inappropriate antibiotic use, less is known about the experiences, perceptions, and contextual factors that influence their implementation and sustainability. Eligibility criteria: This review will include qualitative studies exploring the experiences, perceptions, attitudes, and contextual factors influencing implementation of AMS programs among health care professionals and policymakers. Studies conducted in any health care setting and involving any population relevant to AMS programs will be considered. Methods: The key information sources to be searched for this review will include PubMed, CINAHL (EBSCOhost), PsycINFO (Ovid), Scopus, Embase, and Web of Science Core Collection. The search will include studies published in any language from 2015 onward. Study selection will be conducted independently by 2 reviewers, with any disagreements resolved through discussion or consultation with a third reviewer. All included studies will be critically appraised for methodological quality, and all will proceed to synthesis, regardless of the results of methodological quality assessment. Data relevant to the review objectives will be extracted in terms of both findings and illustrations, followed by an aggregative data synthesis approach. Confidence in the findings will be assessed using a structured grading process based on credibility and dependability. Review registration: PROSPERO CRD420251044164
- 5 February 2026
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (5) , 1024-1034
Open AccessPerspectives of health care professionals and policymakers on antimicrobial stewardship and implementation challenges in low- and middle-income country hospital settings: a qualitative systematic review protocol
Objective: The objective of this review is to synthesize qualitative evidence on the perceptions of health care professionals and policymakers regarding barriers and facilitators to implementing antimicrobial stewardship (AMS) programs in hospital settings, particularly in low- and middle-income countries. Introduction: AMS programs are widely recognized as critical interventions to combat antimicrobial resistance and optimize the use of antibiotics. While quantitative studies have demonstrated the effectiveness of AMS programs in reducing inappropriate antibiotic use, less is known about the experiences, perceptions, and contextual factors that influence their implementation and sustainability. Eligibility criteria: This review will include qualitative studies exploring the experiences, perceptions, attitudes, and contextual factors influencing implementation of AMS programs among health care professionals and policymakers. Studies conducted in any health care setting and involving any population relevant to AMS programs will be considered. Methods: The key information sources to be searched for this review will include PubMed, CINAHL (EBSCOhost), PsycINFO (Ovid), Scopus, Embase, and Web of Science Core Collection. The search will include studies published in any language from 2015 onward. Study selection will be conducted independently by 2 reviewers, with any disagreements resolved through discussion or consultation with a third reviewer. All included studies will be critically appraised for methodological quality, and all will proceed to synthesis, regardless of the results of methodological quality assessment. Data relevant to the review objectives will be extracted in terms of both findings and illustrations, followed by an aggregative data synthesis approach. Confidence in the findings will be assessed using a structured grading process based on credibility and dependability. Review registration: PROSPERO CRD420251044164
- Open Access
- 11 November 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-13
Antimicrobial stewardship programs in primary and secondary care settings in India: current challenges, facilitators, perceptions, and impact – a scoping review
Introduction: Antimicrobial stewardship programs (AMSP) is a major initiative of World Health Organization Global Action Plan (WHO-GAP) to address antimicrobial resistance (AMR). The program aims to promote the rational use of antibiotics to help improve patient outcomes. Existing evidence on AMSPs and their activities is largely restricted to the resource intense settings in India thereby impacting sustainability and adaptation of initiatives within rural/remote region. Aims: The review focus on the current state of AMSP practices in the Indian primary and secondary care settings, identifying the challenges, enablers, perceptions and practice of physicians, and the impact of current AMSP interventions. Methods: We conducted electronic database searches on PubMed, Scopus, and EMBASE, in adherence to the PRISMA-ScR guidelines. Our review identifies four key domains such as barriers to AMSP establishment, facilitators for establishing AMSP, AMSP perceptions and practices among the prescribers, and the impact of AMSP interventions. Results: Among the 4739 articles searched, five studies met the inclusion criteria, in the primary and secondary care clinical settings in India. We focused on articles published after the 2015 post WHO GAP implementation. Barriers to AMSP implementation, including access to the healthcare system, poor regulatory implementation, poor knowledge and awareness about antibiotic regulations and AMR, and lack of awareness in all the studies. Facilitators identified for hospital AMSP implementation include, use of staff engagement, audit feedback and discussion, administrative representation, documentation, interactive sessions and education. Only one study could explore the impacts of AMSP intervention on both clinical and microbiological outcomes. The major outcomes included more appropriate antibiotic prescriptions, reduced consumption of antimicrobials, reduced hospital stays and decrease in mortality rate. Conclusion: The existing evidence based on adaptation and implementation of AMSP is sparse. This study highlights the urgent need for widespread AMSP in the resource-constraint settings of India. Multipronged approach is crucial to encompass skilled human resources, implement facility-specific interventions, develop accessible guidelines for antibiotic use, providing economic support and increasing awareness through capacity-building programs, and can attain effective establishment of AMSPs.
- 11 November 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-13
Open AccessAntimicrobial stewardship programs in primary and secondary care settings in India: current challenges, facilitators, perceptions, and impact – a scoping review
Introduction: Antimicrobial stewardship programs (AMSP) is a major initiative of World Health Organization Global Action Plan (WHO-GAP) to address antimicrobial resistance (AMR). The program aims to promote the rational use of antibiotics to help improve patient outcomes. Existing evidence on AMSPs and their activities is largely restricted to the resource intense settings in India thereby impacting sustainability and adaptation of initiatives within rural/remote region. Aims: The review focus on the current state of AMSP practices in the Indian primary and secondary care settings, identifying the challenges, enablers, perceptions and practice of physicians, and the impact of current AMSP interventions. Methods: We conducted electronic database searches on PubMed, Scopus, and EMBASE, in adherence to the PRISMA-ScR guidelines. Our review identifies four key domains such as barriers to AMSP establishment, facilitators for establishing AMSP, AMSP perceptions and practices among the prescribers, and the impact of AMSP interventions. Results: Among the 4739 articles searched, five studies met the inclusion criteria, in the primary and secondary care clinical settings in India. We focused on articles published after the 2015 post WHO GAP implementation. Barriers to AMSP implementation, including access to the healthcare system, poor regulatory implementation, poor knowledge and awareness about antibiotic regulations and AMR, and lack of awareness in all the studies. Facilitators identified for hospital AMSP implementation include, use of staff engagement, audit feedback and discussion, administrative representation, documentation, interactive sessions and education. Only one study could explore the impacts of AMSP intervention on both clinical and microbiological outcomes. The major outcomes included more appropriate antibiotic prescriptions, reduced consumption of antimicrobials, reduced hospital stays and decrease in mortality rate. Conclusion: The existing evidence based on adaptation and implementation of AMSP is sparse. This study highlights the urgent need for widespread AMSP in the resource-constraint settings of India. Multipronged approach is crucial to encompass skilled human resources, implement facility-specific interventions, develop accessible guidelines for antibiotic use, providing economic support and increasing awareness through capacity-building programs, and can attain effective establishment of AMSPs.
- 1 January 2023
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 14 (1) , 61-85
Current Trends and Future Perspectives for Enhanced Drug Delivery to Central Nervous System in Treatment of Stroke
Stroke, one of the leading causes of death around the globe, is expected to rise considerably by 2050. The expanding nanotechnology science offers a promising future for medical research treating s... Plain language summary A stroke is an emergency medical condition that affects the brain. Stroke is the third leading cause of death in the US and fifth in other developing countries. Taking blood-...
- 1 January 2023
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 14 (1) , 61-85
Current Trends and Future Perspectives for Enhanced Drug Delivery to Central Nervous System in Treatment of Stroke
Stroke, one of the leading causes of death around the globe, is expected to rise considerably by 2050. The expanding nanotechnology science offers a promising future for medical research treating s... Plain language summary A stroke is an emergency medical condition that affects the brain. Stroke is the third leading cause of death in the US and fifth in other developing countries. Taking blood-...
- Open Access
- 2 October 2021
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 12 (3) , 490-508
Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia
Schizophrenia is a neuropsychiatric disorder mainly affecting the central nervous system (CNS), presented with auditory and visual hallucinations, delusion and withdrawal from society. Abnormal dopamine levels mainly characterise the disease; various theories of neurotransmitters explain the pathophysiology of the disease. The current therapeutic approach deals with the systemic administration of drugs other than the enteral route, altering the neurotransmitter levels within the brain and providing symptomatic relief. Fluid biomarkers help in the early detection of the disease, which would improve the therapeutic efficacy. However, the major challenge faced in CNS drug delivery is the blood-brain barrier (BBB). Nanotherapeutic approaches may overcome these limitations, which will improve safety, efficacy, and targeted drug delivery. This review article addresses the main challenges faced in CNS drug delivery and the significance of current therapeutic strategies and nanotherapeutic approaches for a better understanding and enhanced drug delivery to the brain, which improve the quality of life of schizophrenia patients.
- 2 October 2021
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 12 (3) , 490-508
Open AccessNanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia
Schizophrenia is a neuropsychiatric disorder mainly affecting the central nervous system (CNS), presented with auditory and visual hallucinations, delusion and withdrawal from society. Abnormal dopamine levels mainly characterise the disease; various theories of neurotransmitters explain the pathophysiology of the disease. The current therapeutic approach deals with the systemic administration of drugs other than the enteral route, altering the neurotransmitter levels within the brain and providing symptomatic relief. Fluid biomarkers help in the early detection of the disease, which would improve the therapeutic efficacy. However, the major challenge faced in CNS drug delivery is the blood-brain barrier (BBB). Nanotherapeutic approaches may overcome these limitations, which will improve safety, efficacy, and targeted drug delivery. This review article addresses the main challenges faced in CNS drug delivery and the significance of current therapeutic strategies and nanotherapeutic approaches for a better understanding and enhanced drug delivery to the brain, which improve the quality of life of schizophrenia patients.